Inactive/Delisted stock

Cardio Diagnostics Stock (NASDAQ:CDIO)


Chart

Previous Close

$4.52

52W Range

$3.40 - $53.10

50D Avg

$8.79

200D Avg

$12.53

Market Cap

$8.28M

Avg Vol (3M)

$54.16K

Beta

3.05

Div Yield

-

CDIO Company Profile


Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

13

IPO Date

Jan 14, 2022

Website

CDIO Performance


Peer Comparison


TickerCompany
ZURAZura Bio Limited
ZVSAZyVersa Therapeutics, Inc.
AVROAVROBIO, Inc.
PHIOPhio Pharmaceuticals Corp.
SONNSonnet BioTherapeutics Holdings, Inc.
CNSPCNS Pharmaceuticals, Inc.